Kodiak Sciences Statistics
Total Valuation
Kodiak Sciences has a market cap or net worth of $178.94 million. The enterprise value is $107.73 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Kodiak Sciences has 52.63 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | 52.63M |
| Shares Outstanding | 52.63M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 5.54% |
| Owned by Institutions (%) | 49.35% |
| Float | 32.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.64 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.62.
| Current Ratio | 4.62 |
| Quick Ratio | 4.50 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -108.92% and return on invested capital (ROIC) is -50.37%.
| Return on Equity (ROE) | -108.92% |
| Return on Assets (ROA) | -34.10% |
| Return on Invested Capital (ROIC) | -50.37% |
| Return on Capital Employed (ROCE) | -74.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.75M |
| Employee Count | 109 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.59% in the last 52 weeks. The beta is 2.43, so Kodiak Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.43 |
| 52-Week Price Change | +15.59% |
| 50-Day Moving Average | 3.37 |
| 200-Day Moving Average | 4.63 |
| Relative Strength Index (RSI) | 45.31 |
| Average Volume (20 Days) | 440,133 |
Short Selling Information
The latest short interest is 3.36 million, so 6.39% of the outstanding shares have been sold short.
| Short Interest | 3.36M |
| Short Previous Month | 3.61M |
| Short % of Shares Out | 6.39% |
| Short % of Float | 10.40% |
| Short Ratio (days to cover) | 6.78 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -199.87M |
| Pretax Income | -232.75M |
| Net Income | -190.63M |
| EBITDA | -181.26M |
| EBIT | -199.87M |
| Earnings Per Share (EPS) | -$3.62 |
Full Income StatementBalance Sheet
The company has $138.85 million in cash and $67.64 million in debt, giving a net cash position of $71.21 million or $1.35 per share.
| Cash & Cash Equivalents | 138.85M |
| Total Debt | 67.64M |
| Net Cash | 71.21M |
| Net Cash Per Share | $1.35 |
| Equity (Book Value) | 108.84M |
| Book Value Per Share | 2.07 |
| Working Capital | 111.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$106.80 million and capital expenditures -$648,000, giving a free cash flow of -$107.44 million.
| Operating Cash Flow | -106.80M |
| Capital Expenditures | -648,000 |
| Free Cash Flow | -107.44M |
| FCF Per Share | -$2.04 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |